Literature DB >> 15837256

Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism.

Paul Milliez1, Xavier Girerd, Pierre-François Plouin, Jacques Blacher, Michel E Safar, Jean-Jacques Mourad.   

Abstract

OBJECTIVES: The aim of this report was to show that the rate of cardiovascular events is increased in patients with either subtype of primary aldosteronism (PA).
BACKGROUND: Primary aldosteronism involves hypertension (HTN), hypokalemia, and low plasma renin. The two major PA subtypes are unilateral aldosterone-producing adenoma (APA) and bilateral adrenal hyperplasia.
METHODS: During a three-year period, the diagnosis of PA was made in 124 of 5,500 patients referred for comprehensive evaluation and management. Adenomas were diagnosed in 65 patients and idiopathic hyperaldosteronism in 59 patients. During the same period, clinical characteristics and cardiovascular events of this group were compared with those of 465 patients with essential hypertension (EHT) randomly matched for age, gender, and systolic and diastolic blood pressure.
RESULTS: A history of stroke was found in 12.9% of patients with PA and 3.4% of patients with EHT (odds ratio [OR] = 4.2; 95% confidence interval [CI] 2.0 to 8.6]). Non-fatal myocardial infarction was diagnosed in 4.0% of patients with PA and in 0.6% of patients with EHT (OR = 6.5; 95% CI 1.5 to 27.4). A history of atrial fibrillation was diagnosed in 7.3% of patients with PA and 0.6% of patients with EHT (OR = 12.1; 95% CI 3.2 to 45.2). The occurrence of cardiovascular complications was comparable in both subtypes of PA.
CONCLUSIONS: Patients presenting with PA experienced more cardiovascular events than did EHT patients independent of blood pressure. The presence of PA should be detected, not only to determine the cause of HTN, but also to prevent such complications.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15837256     DOI: 10.1016/j.jacc.2005.01.015

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  379 in total

1.  [A 58-year-old hypertensive patient with primary hyperaldosteronism and renal artery stenosis].

Authors:  Michael Nguyen Quang; Bernd Krüger; Christopher D Krüger; Andreas Walberer; Bernhard Schenck; Klaus Kisters; Martin Wenning; Bernhard K Krämer
Journal:  Med Klin (Munich)       Date:  2010-04

2.  Cardiac dimensions are largely determined by dietary salt in patients with primary aldosteronism: results of a case-control study.

Authors:  Eduardo Pimenta; Richard D Gordon; Ashraf H Ahmed; Diane Cowley; Rodel Leano; Thomas H Marwick; Michael Stowasser
Journal:  J Clin Endocrinol Metab       Date:  2011-06-01       Impact factor: 5.958

Review 3.  Diagnosis and treatment of primary aldosteronism.

Authors:  Paolo Mulatero; Silvia Monticone; Franco Veglio
Journal:  Rev Endocr Metab Disord       Date:  2011-03       Impact factor: 6.514

4.  Zona glomerulosa cells of the mouse adrenal cortex are intrinsic electrical oscillators.

Authors:  Changlong Hu; Craig G Rusin; Zhiyong Tan; Nick A Guagliardo; Paula Q Barrett
Journal:  J Clin Invest       Date:  2012-05-01       Impact factor: 14.808

Review 5.  Diagnosis and surgical management for primary hyperaldosteronism.

Authors:  Ravi Munver; Jennifer Yates
Journal:  Curr Urol Rep       Date:  2010-02       Impact factor: 3.092

6.  Laboratory investigation of primary aldosteronism.

Authors:  Michael Stowasser; Paul J Taylor; Eduardo Pimenta; Ashraf H Al-Asaly Ahmed; Richard D Gordon
Journal:  Clin Biochem Rev       Date:  2010-05

7.  46-year-old man with treatment-resistant hypertension.

Authors:  Nicholas M Orme; Phil A Hart; Karen F Mauck
Journal:  Mayo Clin Proc       Date:  2010-10       Impact factor: 7.616

8.  Development of monoclonal antibodies against human CYP11B1 and CYP11B2.

Authors:  Celso E Gomez-Sanchez; Xin Qi; Carolina Velarde-Miranda; Maria W Plonczynski; C Richard Parker; William Rainey; Fumitoshi Satoh; Takashi Maekawa; Yasuhiro Nakamura; Hironobu Sasano; Elise P Gomez-Sanchez
Journal:  Mol Cell Endocrinol       Date:  2013-12-08       Impact factor: 4.102

9.  Prognostic value of semiquantification NP-59 SPECT/CT in primary aldosteronism patients after adrenalectomy.

Authors:  Ching-Chu Lu; Vin-Cent Wu; Kwan-Dun Wu; Kao-Lang Liu; Wei-Chou Lin; Mei-Fang Cheng; Kai-Yuan Tzen; Ruoh-Fang Yen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-02-14       Impact factor: 9.236

10.  Adrenal histologic findings show no difference in clinical presentation and outcome in primary hyperaldosteronism.

Authors:  Allison B Weisbrod; Richard C Webb; Aarti Mathur; Stephanie Barak; Smita Baid Abraham; Naris Nilubol; Martha Quezado; Constantine A Stratakis; Electron Kebebew
Journal:  Ann Surg Oncol       Date:  2012-10-23       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.